Data from the National Cancer Database, which is heavily dependent on institutional reporting, could be misleading about the burden of sarcomas in the United States. READ MORE

Conferences

Health-related quality of life and its impact on disease progression should be a consideration when selecting treatment for sarcoma.

READ MORE

J Code Updates

News

Data from the National Cancer Database, which is heavily dependent on institutional reporting, could be misleading about the burden of sarcomas in the United States.

READ MORE

A recent analysis showed that aftercare strategies for soft-tissue sarcoma are misguided and are in need of time- and risk-adapted methods.

READ MORE

Long-term therapy with a recently approved drug is well tolerated in patients with soft-tissue sarcoma.

READ MORE

A recent analysis examined whether changes to the latest American Joint Committee on Cancer cancer staging manual on retroperitoneal sarcoma have improved staging system performance.

READ MORE

Research in Review

The best potential strategy involving tyrosine kinase inhibitors for the treatment of gastrointestinal stromal tumors has been identified.

READ MORE

Kaposi Sarcoma (KS) skin lesions are more likely to respond to local external beam radiotherapy than repeat radiotherapy.

READ MORE

Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors, supporting efforts for further research.

READ MORE

Neoadjuvant chemotherapy with epirubicin plus ifosfamide improves outcomes in patients with soft tissue sarcoma who are at high-risk of recurrence.

READ MORE